Free Trial

Becton, Dickinson and Company (BDX) Competitors

Becton, Dickinson and Company logo
$174.31 +1.59 (+0.92%)
As of 06/12/2025 03:59 PM Eastern

BDX vs. ISRG, BSX, SYK, MDT, EW, IDXX, RMD, DXCM, STE, and PODD

Should you be buying Becton, Dickinson and Company stock or one of its competitors? The main competitors of Becton, Dickinson and Company include Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), and Insulet (PODD). These companies are all part of the "health care equipment" industry.

Becton, Dickinson and Company vs. Its Competitors

Intuitive Surgical (NASDAQ:ISRG) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

Intuitive Surgical received 453 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 68.88% of users gave Intuitive Surgical an outperform vote while only 62.07% of users gave Becton, Dickinson and Company an outperform vote.

CompanyUnderperformOutperform
Intuitive SurgicalOutperform Votes
1060
68.88%
Underperform Votes
479
31.12%
Becton, Dickinson and CompanyOutperform Votes
607
62.07%
Underperform Votes
371
37.93%

83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 0.7% of Intuitive Surgical shares are held by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Intuitive Surgical presently has a consensus target price of $588.95, indicating a potential upside of 14.81%. Becton, Dickinson and Company has a consensus target price of $219.22, indicating a potential upside of 25.77%. Given Becton, Dickinson and Company's higher probable upside, analysts plainly believe Becton, Dickinson and Company is more favorable than Intuitive Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intuitive Surgical
1 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.70
Becton, Dickinson and Company
0 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.36

Intuitive Surgical has a net margin of 27.81% compared to Becton, Dickinson and Company's net margin of 8.47%. Becton, Dickinson and Company's return on equity of 15.74% beat Intuitive Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Intuitive Surgical27.81% 14.55% 12.88%
Becton, Dickinson and Company 8.47%15.74%7.29%

In the previous week, Intuitive Surgical had 47 more articles in the media than Becton, Dickinson and Company. MarketBeat recorded 68 mentions for Intuitive Surgical and 21 mentions for Becton, Dickinson and Company. Becton, Dickinson and Company's average media sentiment score of 1.27 beat Intuitive Surgical's score of 1.01 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Intuitive Surgical
45 Very Positive mention(s)
6 Positive mention(s)
11 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
Becton, Dickinson and Company
15 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Intuitive Surgical has a beta of 1.67, indicating that its stock price is 67% more volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.25, indicating that its stock price is 75% less volatile than the S&P 500.

Intuitive Surgical has higher earnings, but lower revenue than Becton, Dickinson and Company. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intuitive Surgical$8.71B21.10$2.32B$6.8275.22
Becton, Dickinson and Company$20.87B2.39$1.71B$5.2433.27

Summary

Intuitive Surgical beats Becton, Dickinson and Company on 13 of the 18 factors compared between the two stocks.

Get Becton, Dickinson and Company News Delivered to You Automatically

Sign up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BDX vs. The Competition

MetricBecton, Dickinson and CompanySurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$49.96B$4.37B$5.61B$19.88B
Dividend Yield2.40%42.67%5.28%3.83%
P/E Ratio28.9628.2927.2135.60
Price / Sales2.3970.02408.4943.81
Price / Cash10.7651.0838.2517.51
Price / Book1.955.827.074.85
Net Income$1.71B$67.63M$3.23B$1.02B
7 Day Performance0.48%-1.03%0.68%0.90%
1 Month Performance-0.58%16.63%9.59%2.35%
1 Year Performance-24.86%18.79%32.02%10.79%

Becton, Dickinson and Company Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BDX
Becton, Dickinson and Company
4.9592 of 5 stars
$174.31
+0.9%
$219.22
+25.8%
-25.5%$49.96B$20.87B28.9677,000Positive News
Options Volume
ISRG
Intuitive Surgical
4.7759 of 5 stars
$527.28
-5.3%
$588.95
+11.7%
+19.8%$189.06B$8.71B82.2912,100Positive News
High Trading Volume
BSX
Boston Scientific
4.5971 of 5 stars
$100.42
-1.6%
$116.00
+15.5%
+27.2%$148.57B$17.55B80.3445,000Positive News
SYK
Stryker
4.927 of 5 stars
$382.84
-0.3%
$427.30
+11.6%
+9.8%$146.12B$23.22B49.3351,000Positive News
MDT
Medtronic
4.6522 of 5 stars
$87.77
+0.4%
$97.00
+10.5%
+7.6%$112.57B$33.54B26.6895,000Trending News
Short Interest ↓
EW
Edwards Lifesciences
4.5782 of 5 stars
$76.61
-1.2%
$80.20
+4.7%
-13.6%$44.94B$5.52B10.9917,300Positive News
IDXX
IDEXX Laboratories
3.8526 of 5 stars
$521.52
-0.6%
$536.00
+2.8%
+2.5%$41.89B$3.93B48.8210,800Positive News
Analyst Forecast
RMD
ResMed
4.0755 of 5 stars
$251.86
-0.1%
$259.33
+3.0%
+19.4%$36.93B$5.02B29.748,160Positive News
Insider Trade
DXCM
DexCom
4.8146 of 5 stars
$86.00
-0.8%
$98.32
+14.3%
-29.3%$33.68B$4.15B60.077,600
STE
STERIS
4.5697 of 5 stars
$243.36
-0.1%
$263.83
+8.4%
+7.2%$23.94B$5.46B51.6716,000Ex-Dividend
PODD
Insulet
4.322 of 5 stars
$306.84
-1.6%
$318.41
+3.8%
+51.3%$21.64B$2.20B53.122,600

Related Companies and Tools


This page (NYSE:BDX) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners